IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 217 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $821,000 | -81.8% | 85,655 | -68.4% | 0.01% | -77.3% |
| Q1 2022 | $4,516,000 | +9.6% | 271,204 | +25.6% | 0.04% | +18.9% |
| Q4 2021 | $4,122,000 | -13.2% | 215,933 | +12.1% | 0.04% | -15.9% |
| Q3 2021 | $4,750,000 | +22.2% | 192,629 | +29.0% | 0.04% | +22.2% |
| Q2 2021 | $3,887,000 | -14.7% | 149,376 | +3.8% | 0.04% | -20.0% |
| Q1 2021 | $4,555,000 | -0.6% | 143,862 | +45.7% | 0.04% | -2.2% |
| Q4 2020 | $4,582,000 | +955.8% | 98,747 | +524.0% | 0.05% | +820.0% |
| Q2 2020 | $434,000 | -52.5% | 15,825 | -48.1% | 0.01% | -61.5% |
| Q1 2020 | $913,000 | -27.0% | 30,504 | -32.5% | 0.01% | -7.1% |
| Q4 2019 | $1,251,000 | +338.9% | 45,213 | +189.1% | 0.01% | +366.7% |
| Q3 2019 | $285,000 | +75.9% | 15,641 | +137.0% | 0.00% | +50.0% |
| Q2 2019 | $162,000 | – | 6,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |